163 related articles for article (PubMed ID: 26175308)
1. Functional outcomes in Rett syndrome.
Pidcock FS; Salorio C; Bibat G; Swain J; Scheller J; Shore W; Naidu S
Brain Dev; 2016 Jan; 38(1):76-81. PubMed ID: 26175308
[TBL] [Abstract][Full Text] [Related]
2. [Methyl-CpG-binding protein 2 gene and CDKL5 gene mutation in patients with Rett syndrome: analysis of 177 Chinese pediatric patients].
Li MR; Pan H; Bao XH; Zhu XW; Cao GN; Zhang YZ; Wu XR
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):224-9. PubMed ID: 19552836
[TBL] [Abstract][Full Text] [Related]
3. Circulating 4-F
Signorini C; Leoncini S; Durand T; Galano JM; Guy A; Bultel-Poncé V; Oger C; Lee JC; Ciccoli L; Hayek J; De Felice C
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921863
[TBL] [Abstract][Full Text] [Related]
4. [Mutation spectrum and genotype-phenotype correlation of MECP2 in patients with Rett syndrome].
Kondo I; Yamagata H
No To Hattatsu; 2002 May; 34(3):219-23. PubMed ID: 12030010
[TBL] [Abstract][Full Text] [Related]
5. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders.
Wong VC; Li SY
J Child Neurol; 2007 Dec; 22(12):1397-400. PubMed ID: 18174559
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
[TBL] [Abstract][Full Text] [Related]
7. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.
Li MR; Pan H; Bao XH; Zhang YZ; Wu XR
J Hum Genet; 2007; 52(1):38-47. PubMed ID: 17089071
[TBL] [Abstract][Full Text] [Related]
8. [Application of long range polymerase chain reaction and DNA direct sequencing in diagnosis of Rett syndrome].
Li MR; Pan H; Bao XH; Cao GN; Wu XR
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):579-82. PubMed ID: 18021529
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome.
Inui K; Akagi M; Ono J; Tsukamoto H; Shimono K; Mano T; Imai K; Yamada M; Muramatsu T; Sakai N; Okada S
Brain Dev; 2001 Jul; 23(4):212-5. PubMed ID: 11376998
[TBL] [Abstract][Full Text] [Related]
10. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.
Neul JL; Fang P; Barrish J; Lane J; Caeg EB; Smith EO; Zoghbi H; Percy A; Glaze DG
Neurology; 2008 Apr; 70(16):1313-21. PubMed ID: 18337588
[TBL] [Abstract][Full Text] [Related]
11. Level of purposeful hand function as a marker of clinical severity in Rett syndrome.
Downs J; Bebbington A; Jacoby P; Williams AM; Ghosh S; Kaufmann WE; Leonard H
Dev Med Child Neurol; 2010 Sep; 52(9):817-23. PubMed ID: 20345957
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome.
Chae JH; Hwang YS; Kim KJ
J Child Neurol; 2002 Jan; 17(1):33-6. PubMed ID: 11913567
[TBL] [Abstract][Full Text] [Related]
13. Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome.
Hettiarachchi D; Neththikumara NF; Pathirana BAPS; Dissanayake VHW
J Autism Dev Disord; 2020 Jan; 50(1):118-126. PubMed ID: 31535341
[TBL] [Abstract][Full Text] [Related]
14. Social impairments in Rett syndrome: characteristics and relationship with clinical severity.
Kaufmann WE; Tierney E; Rohde CA; Suarez-Pedraza MC; Clarke MA; Salorio CF; Bibat G; Bukelis I; Naram D; Lanham DC; Naidu S
J Intellect Disabil Res; 2012 Mar; 56(3):233-47. PubMed ID: 21385260
[TBL] [Abstract][Full Text] [Related]
15. Genotype and early development in Rett syndrome: the value of international data.
Leonard H; Moore H; Carey M; Fyfe S; Hall S; Robertson L; Wu XR; Bao X; Pan H; Christodoulou J; Williamson S; Klerk Nd
Brain Dev; 2005 Nov; 27 Suppl 1():S59-S68. PubMed ID: 16182492
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of novel sequence variations in MECP2 gene in Rett syndrome patients.
Monnerat LS; Moreira Ados S; Alves MC; Bonvicino CR; Vargas FR
Brain Dev; 2010 Nov; 32(10):843-8. PubMed ID: 20031356
[TBL] [Abstract][Full Text] [Related]
17. Rett syndrome and long-term disorder profile.
Smeets EE; Chenault M; Curfs LM; Schrander-Stumpel CT; Frijns JP
Am J Med Genet A; 2009 Feb; 149A(2):199-205. PubMed ID: 19133691
[TBL] [Abstract][Full Text] [Related]
18. [Clinical symptoms of the Rett syndrome patients with MECP2 gene abnormalities].
Miura K; Kumagai T; Suzuki Y; Ohki T; Matsumoto A; Miyazaki S; Hayakawa C; Sonta S; Yamada Y; Wakamatsu N
No To Hattatsu; 2005 Jan; 37(1):39-45. PubMed ID: 15675358
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
Brown K; Selfridge J; Lagger S; Connelly J; De Sousa D; Kerr A; Webb S; Guy J; Merusi C; Koerner MV; Bird A
Hum Mol Genet; 2016 Feb; 25(3):558-70. PubMed ID: 26647311
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome.
Caffarelli C; Gonnelli S; Pitinca MDT; Camarri S; Al Refaie A; Hayek J; Nuti R
BMC Med Genet; 2020 Jan; 21(1):21. PubMed ID: 32005172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
